Arachidic Acid

Arachidic Acid

SCHEMBL7629162

CCCCCCCCCCCCCCCCCCCC(=O)O.[CaH2]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.94
PPARG P37231 7/20 0.94
PPARD Q03181 7/20 0.94
PPARA Q07869 7/20 0.94
HDAC11 Q96DB2 5/20 0.94
TSHR P16473 4/20 0.94
PTPN1 P18031 3/20 0.94
FABP4 P15090 3/20 0.94
ALDH1A1 P00352 2/20 0.94
TLR2 O60603 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
KMT2A Q03164 2/20 0.94
ALOX15 P16050 2/20 0.94
HSD17B10 Q99714 2/20 0.94
SLC22A6 Q4U2R8 1/20 0.94
SLC22A8 Q8TCC7 1/20 0.94
MEN1 O00255 1/20 0.94
ESR1 P03372 1/20 0.94
PDE4A P27815 1/20 0.94
PDE3A Q14432 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Undecanoate SCHEMBL11343021 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
N-Octacosanoic Acid SCHEMBL511103 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL4394422 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL988156 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL9710143 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL93399 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8743133 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL360185 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL12487275 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11
Hexacosanoic Acid SCHEMBL8743132 1.00 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109824995-A A kind of anti-aging Masterbatch of PVC 合肥旭弘塑胶制品有限公司 2019-05-31 CN claimed
CN-108559155-A Biodegradable plastic base material 韩其洋 2018-09-21 CN claimed
CN-108219240-A Engineering plastics filling master batch 韩其洋 2018-06-29 CN claimed
CN-108102246-A High-weatherability plastic color master grain 韩其洋 2018-06-01 CN claimed
CN-107095799-B Complex liposome and its preparation method and application 广州市禾基生物科技有限公司 2018-03-27 CN claimed
CN-107308454-A Liposome and its preparation method and application 广州市禾基生物科技有限公司 2017-11-03 CN claimed
CN-102869343-B low concentration meloxicam tablets BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2016-12-14 CN claimed
CN-104981235-A Pharmaceutical composition comprising n-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof HEXAL AG 2015-10-14 CN claimed
CN-103816127-A Oral dosage form comprising tri-substituted glycerol compounds ALPHAPTOSE GMBH 2014-05-28 CN claimed
CN-102869343-A Novel low concentration meloxicam tablets BOEHRINGER INGELHEIM VETMED 2013-01-09 CN claimed
CN-101610758-A Oral dosage forms containing tri-substituted glycerol compounds ALPHAPTOSE GMBH (DE) 2009-12-23 CN claimed
CN-116082759-B Gamma ray resistant modified PVC granule and application thereof 浙江天原医用材料有限公司 2024-06-25 CN disclosed
CN-116376186-A Antibacterial and anti-aging PVC color master batch and preparation method thereof 广东银豪塑胶制品有限公司 2023-07-04 CN disclosed
CN-116082759-A Gamma ray resistant modified PVC granule and application thereof 浙江天原医用材料有限公司 2023-05-09 CN disclosed
CN-108291016-B Polycarbonate resin, method for producing same, and film 帝人株式会社 2021-08-17 CN disclosed
CN-1148728-A Electronic emission device, elelctronic source and picture formation device, and production method thereof CANON KK (JP) 1997-04-30 CN disclosed
CN-1058715-A Ifosfamide is the solid orally ingestible of active component ASTA PHARMA AG (DE) 1992-02-19 CN disclosed
US-4269731-A DISCOLORATION INHIBITION; MOLDING MATERIALS ARGUS CHEMICAL CORPORATION (US) 1981-05-26 US disclosed
US-4256618-A DISCOLORATION INHIBITION DURING EARLY HEATING; SYNERGISTIC ARGUS CHEMICAL CORPORATION (US) 1981-03-17 US disclosed
EP-0024919-A2 Process for providing monovalent and polyvalent metal, particularly antimony, mercaptocarboxylic acid ester salts; monovalent and polyvalent metal mercaptocarboxylic acid salts; polyol mercaptocarboxylic acid monoesters, and esters of such polyol mercaptocarboxylic acid esters with a mercaptocarboxylic acid; stabilizer compositions for polyvinyl chloride resins comprising such compounds; and polyvinyl chloride resin compositions comprising a stabilizing amount of such compounds Mack, Gerry (US) 1981-03-11 EP disclosed